Judge voids $48 million arbitration award after finding United Networks committed fraud
A 7-year private arbitration never surfaced the concealed documents; the fraud came out only through a separate public lawsuit where a judge pierced privilege under the crime-fraud exception. Arbitration's privacy and narrow review protect finality and also protect a party willing to lie. Every party is held to scrutiny: UNA (fraud), OptumRx (not fully forthcoming; separate FTC insulin case), and the system.
A 7-year private arbitration never surfaced the concealed documents; the fraud came out only through a separate public lawsuit where a judge pierced privilege under the crime-fraud exception. Arbitration's privacy and narrow review protect finality and also protect a party willing to lie. Every party is held to scrutiny: UNA (fraud), OptumRx (not fully forthcoming; separate FTC insulin case), and the system.
Senior U.S. District Judge Timothy Corrigan on Oct. 2 unsealed an order vacating in full a $48,362,033 arbitration award to discount-card company United Networks of America against OptumRx, finding UNA's acquisition story was a lie and the award was procured by fraud.
Why it matters: Discount-card commissions are paid from prescription claim revenue; PBM rebate flows remain opaque to employers and patients; consumers and workers sign arbitration clauses with the same privacy and narrow review.
Date to watch: OptumRx motion for attorneys' fees (filed Oct. 1, 2026); any UNA appeal to the 11th Circuit; the Colorado case against NBBI.
Sources:
- Final Order, OptumRx PBM of Illinois v. United Networks of America (M.D. Fla.) (2026-10-02)
https://storage.courtlistener.com/recap/gov.uscourts.flmd.420452/gov.uscourts.flmd.420452.111.0.pdf - CourtListener docket 3:23-cv-01308 (M.D. Fla.) (2026-10-02)
https://www.courtlistener.com/docket/67962492/optumrx-pbm-of-illinois-inc-v-united-networks-of-america-inc/ - 9 U.S. Code § 10: grounds for vacating an arbitration award (1947-07-30)
https://www.law.cornell.edu/uscode/text/9/10 - FTC: suit against PBMs over insulin prices (2024-09-20)
https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices - Gibson Dunn (OptumRx's counsel): court vacates award (2026-10-02)
https://www.gibsondunn.com/u-s-district-court-vacates-in-full-a-nearly-50-million-arbitration-award-against-gibson-dunn-client-optumrx/ - Business Law Pros: challenging a binding arbitration award (2025-12-02)
https://www.youtube.com/watch?v=Cc-odrMYRhg - Senate hearing: Sen. Tina Smith on secret arbitration outcomes (2022-03-13)
https://www.youtube.com/watch?v=w4ciaf34yLc - Sen. Sheldon Whitehouse on ending forced arbitration (2021-11-04)
https://www.youtube.com/watch?v=7x_p5pQhf0g - NBC News: PBMs under fire in House hearing (2024-07-24)
https://www.youtube.com/watch?v=JKbhGMRJ-30 - Sen. Richard Blumenthal questions PBM witnesses on rebates (2025-05-14)
https://www.youtube.com/watch?v=_uFI8kQ8plc - Rep. Deborah Ross to FTC Chair on PBMs (2023-08-29)
https://www.youtube.com/watch?v=exHY4DN-vi8 - NewsNation: FTC sues the three largest PBMs over insulin (2024-09-23)
https://www.youtube.com/watch?v=GyWJ3rCsvXI - LiveNOW from FOX: Antonio Ciaccia on FTC PBM insulin suit (2024-09-21)
https://www.youtube.com/watch?v=UNwB2Kcao0k
The Throughline decodes today's headline — with receipts. Every claim is sourced; links below.
Subscribe and stand the watch. — Last Bastion